Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00026312
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-15
First Post:
2001-11-09
Brief Title:
Isotretinoin With or Without Dinutuximab Aldesleukin and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage 4S Neuroblastoma |
| Localized Resectable Neuroblastoma |
| Localized Unresectable Neuroblastoma |
| Recurrent Neuroblastoma |
| Regional Neuroblastoma |
| Stage 4 Neuroblastoma |
Keywords: